"10.1371_journal.pone.0126363","plos one","2015-05-07T00:00:00Z","Ren Matsuba; Kensuke Sakai; Minako Imamura; Yasushi Tanaka; Minoru Iwata; Hiroshi Hirose; Kohei Kaku; Hiroshi Maegawa; Hirotaka Watada; Kazuyuki Tobe; Atsunori Kashiwagi; Ryuzo Kawamori; Shiro Maeda","Laboratory for Endocrinology, Metabolism and Kidney Diseases, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan; Department of Internal Medicine, Division of Metabolism and Endocrinology, St. Marianna University School of Medicine, Kawasaki, Japan; First Department of Internal Medicine, University of Toyama, Toyama, Japan; Community Medical Support Unit, Faculty of Medicine, University of Toyama, Toyama, Japan; Health Center, Keio University School of Medicine, Tokyo, Japan; Department of Internal Medicine, Kawasaki Medical School, Kurashiki, Japan; Department of Medicine, Shiga University of Medical Science, Otsu, Japan; Department of Metabolism and Endocrinology, Juntendo University Graduate School of Medicine, Tokyo, Japan; Sportology Center, Juntendo University Graduate School of Medicine, Tokyo, Japan; Department of Advanced Genomic and Laboratory Medicine, Graduate School of Medicine, University of the Ryukyus, Nishihara, Japan","Conceived and designed the experiments: M. Imamura SM. Performed the experiments: RM KS M. Imamura SM. Analyzed the data: RM KS M. Imamura SM. Contributed reagents/materials/analysis tools: RM KS YT M. Iwata HH KK HM HW KT AK RK. Wrote the paper: RM M. Imamura SM. Interpretation of data for the work: YT M. Iwata HH KK HM HW KT AK RK.","HW is a member of advisory panel of Novo Nordisk Pharma, Sanofi, Dainippon Sumitomo Pharma, Mochida Pharmaceutical Co, MSD, Takeda Pharmaceutical Co, Boehringer Ingelheim, Ono Pharmaceutical Co., Novartis Pharmaceuticals, Mitsubishi-Tanabe Pharma, AstraZeneca, Kowa Co. Astellas Pharma Inc., Pfizer Inc., has received lecture fees from Novo Nordisk Pharma, Eli Lilly Japan, Sanofi, Dainippon Sumitomo Pharma, Fujifilm, Bayer, Kissei Phamaceutical Co., Mochida Pharmaceutical Co, MSD, Takeda Pharmaceutical Co, Boehringer Ingelheim, Daiichi Sankyo, Inc, Ono Pharmaceutical Co. Novartis Pharmaceuticals, Boehringer Ingelheim, Mitsubishi-Tanabe Pharma, AstraZeneca, Kyowa Hokko Kirin Co, Sanwa Kagaku Kenkyusho Co, Kowa Co. Astellas Pharma Inc., Pfizer Inc., and received research funds from Johnson & Johnson, Kyowa Hokko Kirin Co., Kissei Phamaceutical Co., Bristol-Myers Squibb, Novo Nordisk Pharma, Astellas Pharma Inc., MSD, Dainippon Sumitomo Pharma., AstraZeneca, Teijin Pharma, Mochida Pharmaceutical Co., Sanofi, Sanwa Kagaku Kenkyusho Co., Boehringer Ingelheim, Pfizer Inc., Novartis Pharmaceuticals, Ono Pharmaceutical Co., Mitsubishi-Tanabe Pharma, Daiichi Sankyo, Inc, Takeda Pharmaceutical Co., Eli Lilly Japan, Taisho Toyama Pharmaceutical Co. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.","2015","05","Ren Matsuba","RM",13,TRUE,1,3,3,2,TRUE,TRUE,TRUE,6,"6;7;9;10;11;12",TRUE
